Sari Fishman - 18 Mar 2026 Form 3 Insider Report for Can-Fite BioPharma Ltd. (CANF)

Role
VP Business Development
Signature
/s/ Sari Fishman
Issuer symbol
CANF
Transactions as of
18 Mar 2026
Net transactions value
$0
Form type
3
Filing time
18 Mar 2026, 08:12:17 UTC
SEC
View on sec.gov

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
Fishman Sari VP Business Development C/O CAN-FITE BIOPHARMA LTD., 26 BEN GURION STREET, RAMAT GAN, ISRAEL /s/ Sari Fishman 18 Mar 2026 0002116402

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
holding CANF Options to Purchase Ordinary Shares 18 Mar 2026 Ordinary Shares 26 $3537.03 Direct F1, F2, F3
holding CANF Options to Purchase Ordinary Shares 18 Mar 2026 Ordinary Shares 50 $2427.24 Direct F1, F2, F4
holding CANF Options to Purchase Ordinary Shares 18 Mar 2026 Ordinary Shares 40 $2264.01 Direct F1, F2, F5
holding CANF Options to Purchase Ordinary Shares 18 Mar 2026 Ordinary Shares 333 $241.47 Direct F1, F2, F6
holding CANF Options to Purchase Ordinary Shares 18 Mar 2026 Ordinary Shares 500 $247.36 Direct F1, F2, F7
holding CANF Options to Purchase Ordinary Shares 18 Mar 2026 Ordinary Shares 500 $241.47 Direct F1, F8
holding CANF Options to Purchase Ordinary Shares 18 Mar 2026 Ordinary Shares 1,666 $25.21 Direct F1, F9
holding CANF Options to Purchase Ordinary Shares 18 Mar 2026 Ordinary Shares 1,666 $26.56 Direct F1, F10
holding CANF Options to Purchase Ordinary Shares 18 Mar 2026 Ordinary Shares 1,666 $17.39 Direct F1, F11
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 To qualify for certain tax benefits under Section 102 of the Israeli Tax Ordinance, securities issued to an employee in connection with the Issuer's 2003 Share Option Plan, 2013 Share Option Plan and 2023 Share Option Plan must be registered in the name of a trustee.
F2 These options are fully vested and exercisable as of the date hereof.
F3 The exercise price of this option, originally denominated in New Israeli Shekels ("NIS") in the amount of NIS 10,986, is presented in the table in U.S. dollars ("USD") based on the exchange rate reported by the Bank of Israel on March 11, 2026, which was NIS 3.106 = USD 1.00.
F4 The exercise price of this option, originally denominated in NIS in the amount of NIS 7,539, is presented in the table in USD based on the exchange rate reported by the Bank of Israel on March 11, 2026, which was NIS 3.106 = USD 1.00.
F5 The exercise price of this option, originally denominated in NIS in the amount of NIS 7,032, is presented in the table in USD based on the exchange rate reported by the Bank of Israel on March 11, 2026, which was NIS 3.106 = USD 1.00.
F6 The exercise price of this option, originally denominated in NIS in the amount of NIS 750, is presented in the table in USD based on the exchange rate reported by the Bank of Israel on March 11, 2026, which was NIS 3.106 = USD 1.00.
F7 The exercise price of this option, originally denominated in NIS in the amount of NIS 768.3, is presented in the table in USD based on the exchange rate reported by the Bank of Israel on March 11, 2026, which was NIS 3.106 = USD 1.00.
F8 The exercise price of this option, originally denominated in NIS in the amount of NIS 750, is presented in the table in USD based on the exchange rate reported by the Bank of Israel on March 11, 2026, which was NIS 3.106 = USD 1.00. Of the options reported herein 437 options are vested, and the remaining 63 options vest in two equal quarterly installments beginning 04/17/2026 and ending 07/17/2026 subject to the Reporting Person's continued service to the Issuer as of such vesting date.
F9 The exercise price of this option, originally denominated in NIS in the amount of NIS 78.3, is presented in the table in USD based on the exchange rate reported by the Bank of Israel on March 11, 2026, which was NIS 3.106 = USD 1.00. Of the options reported herein 1,145 options are vested, and the remaining 521 options vest in five equal quarterly installments beginning 04/01/2026 and ending 04/01/2027 subject to the Reporting Person's continued service to the Issuer as of such vesting date.
F10 The exercise price of this option, originally denominated in NIS in the amount of NIS 82.5, is presented in the table in USD based on the exchange rate reported by the Bank of Israel on March 11, 2026, which was NIS 3.106 = USD 1.00. Of the options reported herein 728 options are vested, and the remaining 938 options vest in nine equal quarterly installments beginning 05/07/2026 and ending 05/07/2028 subject to the Reporting Person's continued service to the Issuer as of such vesting date.
F11 The exercise price of this option, originally denominated in NIS in the amount of NIS 54, is presented in the table in USD based on the exchange rate reported by the Bank of Israel on March 11, 2026, which was NIS 3.106 = USD 1.00. Of the options reported herein 312 options are vested, and the remaining 1,354 options vest in thirteen equal quarterly installments beginning 04/29/2026 and ending 04/29/2029 subject to the Reporting Person's continued service to the Issuer as of such vesting date.